News | October 24, 2012

Varian Medical Systems Receives Clearance to Market the Unique Radiotherapy System in China

Radiation Therapy Varian UNIQUE China

October 24, 2012 — Varian Medical Systems Inc., manufacturer of medical technology for treating cancer with radiotherapy, announced that China's State Food and Drug Administration (SFDA) has granted clearance to market the UNIQUE medical linear accelerator, a single-energy machine for treating cancer with advanced forms of image-guided radiotherapy. The versatile UNIQUE system can be used to deliver intensity-modulated radiotherapy (IMRT) and RapidArc treatments, which precisely target tumors while minimizing exposure of surrounding healthy tissues.

The UNIQUE radiotherapy system is the world's first low-energy (6MV) radiotherapy system that can be outfitted with high-tech image-guidance, beam shaping, and RapidArc technology for rapid treatment delivery. It also includes the latest release of Varian's market leading Eclipse treatment planning software, offering clinicians a seamless workflow for planning and delivering advanced radiotherapy treatments. It is a cost effective solution designed to make access to quality care more widely available to cancer patients around the world.

"Epidemiological data show that more than 2.2 million new cancer cases are diagnosed in China each year," said Tom Duffy, head of Varian's Oncology Systems business in Asia. "This presents the dedicated clinicians in China with daunting numbers of patients in need of treatment. Many departments operate two or three shifts to keep up with the demand for access to radiotherapy treatment. In recognition of the challenge, the Chinese Ministry of Health has announced a dramatic increase in the number of licenses available to hospitals for the purchase of additional accelerators. Varian created the UNIQUE system to help address the need for greater access to care in China and other parts of the world."

The UNIQUE system can be used to deliver RapidArc radiotherapy, an arc-based approach that makes it possible to complete an image-guided IMRT treatment in a matter of minutes — up to four times faster than is possible with conventional IMRT.

The UNIQUE system is ideally equipped for treating cancer of the head and neck, breast, cervix, lung, prostate and other tumors. It is available in two configurations: UNIQUE Performance Edition, which incorporates all the tools needed for image-guided RapidArc radiotherapy, and UNIQUE Power Edition, a more basic platform that can be upgraded at a later time. Either package is ideal for treatment centers looking to transition from older cobalt units to modern radiotherapy technology. The small footprint of the UNIQUE accelerator allows it to fit into most small, existing treatment vaults.

For more information: www.varian.com

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init